Product Center

PANTA™/F (50 tests)



Cat. # Description Qty. Unit
442188 PANTA™/F (50 tests)
10 SP

Intended Use:

BACTEC™ PANTA™/F Antimicrobial Supplement is recommended as an addition to BACTEC MYCO/F-Sputa Medium for the primary isolation of mycobacteria from clinical specimens. PANTA/F suppresses the normal flora associated with digested and decontaminated specimens. Principal use is with the BACTEC brand 9000MB instrument.


Catalog # Description Quantity Unit
442188 PANTA™/F (50 tests)
10 SP

BACTEC™ PANTA™/F Antimicrobial Supplement
Revision: 2010/07     Revision Date: 07/01/2010    

Intended Use:

BACTEC™ PANTA™/F Antimicrobial Supplement is recommended as an addition to BACTEC MYCO/F-Sputa Medium for the primary isolation of mycobacteria from clinical specimens. PANTA/F suppresses the normal flora associated with digested and decontaminated specimens. Principal use is with the BACTEC brand 9000MB instrument.



Product Summary:

Since the BACTEC system utilizes a liquid medium, it is important to add an antimicrobial supplement to suppress growth of contaminating microorganisms which may survive the decontamination process. PANTA/F is a lyophilized mixture of five antimicrobials that is reconstituted with Supplement/F. Two mL of the reconstituted PANTA/F is added to each MYCO/F-Sputa Medium vial which then is inoculated with a specimen. The culture vial is incubated and tested on a BACTEC brand 9000MB instrument for the detection of mycobacteria.



User Quality Control:

Do not use vials past their expiration date.

DO NOT use vials that exhibit any cracks or defects; discard the vial in the appropriate manner.

Quality Control Certificates are provided with each kit of BACTEC PANTA/F. Quality control certificates show test organisms utilized for this type of product.

For information on quality control for the BACTEC 9000MB instrument, refer to the BACTEC 9000MB User's Manual (MA-0092).

Quality control requirements must be performed in accordance with applicable local, state and/or federal regulations or accreditation requirements and your laboratory's standard Quality Control procedures. It is recommended that the user refer to pertinent NCCLS guidance and CLIA regulations for appropriate Quality Control practices.



Reagents:

PANTA/F vials contain the following active ingredients prior to processing:

Ingredients per vial of lyophilized agents:

  Approximate formula per vial:
  Polymyxin B  10,000   units
  Amphotericin B  1,000   µg
  Nalidixic Acid  4,000   µg
  Trimethoprim  1,000   µg
  Azlocillin  1,000   µg
 


Warnings and Precautions:

For in vitro Diagnostic Use.

This Product Contains Dry Natural Rubber.

Pathogenic microorganisms, including hepatitis viruses and Human Immunodeficiency Virus, may be present in clinical specimens. "Standard Precautions"1-4 and institutional guidelines should be followed in handling all items contaminated with blood and other body fluids.

Prior to use, the user should examine the vials for evidence of damage or deterioration. Vials that exhibit evidence of damage should be discarded prior to inoculation. Vials displaying turbidity, contamination, or discoloration (darkening) should not be used. On rare occasions, the glass bottle neck may be cracked and the neck may break during removal of the flip-off cap or in handling. Also, on rare occasions a vial may not be sealed sufficiently. In both cases the contents of the vials may leak or spill.

For use with MYCO/F-Sputa Medium; read and follow instructions and information (PP101JAA) supplied with that product.

Reconstitute the PANTA/F vial only with Supplement/F. DO NOT add PANTA/F to MYCO/F-Sputa Medium culture vials more than 2 h prior to the inoculation of specimens.



Information shown on this page is a short summary extracted from the Package Insert, available as a PDF under the Related Documents section of this page.